• $40.5M
    Market Cap
  • 8.16%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
06/30/2025
06/30/2024
06/30/2023
06/30/2022
Income Statement
Total Operating Revenue
0
N/A
0
N/A
0
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
0
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-5.5M
+2.06%
-5.4M
-14.94%
-6.4M
+10.50%
-5.8M
-5.39%
Depreciation and Amortization Expense
8,269
-0.01%
8,270
0.00%
8,270
0.00%
8,270
0.00%
Total Operating Expenses
9.6M
+12.63%
8.5M
-4.78%
8.9M
+10.23%
8.1M
-7.21%
Operating Profit
-9.6M
+12.63%
-8.5M
-4.78%
-8.9M
+10.23%
-8.1M
-7.21%
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
-49,808
0.00%
-49,808
+5,210.02%
-938
-81.69%
-5,123
-94.00%
Interest Income and Expense and Net
-49,808
0.00%
-49,808
+5,210.02%
-938
-81.69%
-5,123
-94.00%
Total Nonoperating Income and Expense
124,679
-43.83%
221,965
-37.46%
354,895
+5,168.63%
6,736
+108.63%
Income before Taxes
-9.6M
+12.63%
-8.5M
-4.78%
-8.9M
+10.32%
-8.1M
-8.11%
Income Taxes
0
N/A
0
N/A
0
N/A
0
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-9.5M
+14.14%
-8.3M
-3.43%
-8.6M
+5.94%
-8.1M
-8.11%
Net Income from Continuing Operations Applicable to Common
-9.5M
+14.14%
-8.3M
-3.43%
-8.6M
+5.94%
-8.1M
-8.11%
Basic EPS and Net Income
-0.63
-10.00%
-0.70
-5.41%
-0.74
+5.71%
-0.70
-13.58%
Diluted EPS and Net Income
-0.63
-10.00%
-0.70
-5.41%
-0.74
+5.71%
-0.70
-13.58%
Basic Weighted Average Shares
15.1M
+27.34%
11.9M
+2.11%
11.6M
+0.79%
11.5M
+5.81%
Diluted Weighted Average Shares
15.1M
+27.34%
11.9M
+2.11%
11.6M
+0.79%
11.5M
+5.81%
Balance Sheet
Cash and Cash Equivalents
1.6M
-66.65%
4.8M
-41.13%
8.1M
-42.06%
14.1M
-31.44%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
1.6M
-66.65%
4.8M
-41.13%
8.1M
-42.06%
14.1M
-31.44%
Total Current Assets
1.7M
-66.39%
5.0M
-41.14%
8.4M
-41.42%
14.4M
-30.77%
Accumulated Depreciation
8.2M
+9.87%
7.5M
+11.20%
6.7M
+12.40%
6.0M
+13.62%
Property and Plant and Equipment and Net
6.8M
-9.03%
7.5M
-7.33%
8.1M
-6.76%
8.7M
-4.30%
Total Long-Term Assets
6.8M
-9.03%
7.5M
+52,211.56%
14,361
-66.16%
42,440
+1,107.40%
Total Assets
8.8M
-31.18%
12.8M
-24.12%
16.9M
-28.07%
23.5M
-22.36%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
2.0M
0.00%
2.0M
N/A
N/A
N/A
1.1M
0.00%
Total Current Liabilities
1.3M
-3.85%
1.4M
+154.33%
534,250
+29.41%
412,837
+17.57%
Total Long-Term Debt
N/A
N/A
1.5M
-5.94%
1.6M
+1,582.48%
94,788
-0.54%
Total Long-Term Liabilities
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Liabilities
1.3M
-3.85%
1.4M
-33.21%
2.0M
+392.75%
412,837
+17.57%
Retained Earnings
-148.8M
+6.79%
-139.4M
+6.33%
-131.1M
+7.01%
-122.5M
+7.09%
Total Stockholders Equity
7.5M
-34.43%
11.5M
-22.88%
14.9M
-35.60%
23.1M
-22.83%
Total Shares Outstanding
16.6M
+26.34%
13.1M
+12.36%
11.7M
+0.92%
11.6M
+0.67%
Cash Flow
Cash from Operating Activities
-8.5M
+34.25%
-6.3M
+11.38%
-5.7M
-3.75%
-5.9M
-28.28%
Capital Expenditures
56,964
-63.62%
156,560
+3.20%
151,712
-53.23%
324,348
+35.84%
Cash from Investing Activities
-56,964
-63.62%
-156,560
+3.20%
-151,712
N/A
N/A
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
5.3M
+69.76%
3.1M
+3,391.59%
-94,788
-59.62%
-234,716
-101.54%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-87.47%
+56.72%
-55.81%
+31.25%
-42.52%
+40.99%
-30.16%
-7.39%
Return on Equity
-99.75%
+58.33%
-63.00%
+39.18%
-45.27%
+47.95%
-30.60%
-10.40%
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
1.28
-65.04%
3.66
-76.86%
15.81
-54.73%
34.92
-41.11%
Cash Ratio
1.22
-65.32%
3.53
-76.85%
15.25
-55.23%
34.07
-41.68%
Debt-to-Equity Ratio
N/A
N/A
0.31
N/A
N/A
N/A
0.05
+29.50%
Debt-to-Assets Ratio
N/A
N/A
0.27
N/A
N/A
N/A
0.05
+28.86%

Earnings & Revenue History

Debt-to-Assets

Cash Flow